A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: day (1000), time (1000)

Risk-reducing bilateral salpingo-oophorectomy - patient information

Description
This booklet explains what a risk-reducing bilateral salpingo-oophorectomy is and what the operation involves to help you decide whether
Url
/Media/UHS-website-2019/Patientinformation/Genetics/Risk-reducing-bilateral-salpingo-oophorectomy-1434-PIL.pdf

Low-dose aspirin (150mg) in pregnancy - patient information

Description
This factsheet provides information about the use of low-dose aspirin (150mg) in pregnancy, including the benefits and risks.
Url
/Media/UHS-website-2019/Patientinformation/Pregnancyandbirth/Low-dose-aspirin-150mg-in-pregnancy-2239-PIL.pdf

Wessex leaflet - why does my GP want to reduce my painkillers

Description
Why does my GP want to reduce my pain killers? If you are in pain, you may feel that the idea
Url
/Media/UHS-website-2019/Docs/Services/Pain/Wessex-leaflet-why-does-my-GP-want-to-reduce-my-painkillers.pdf

Premature ovarian insufficiency - patient information

Description
We have given you this factsheet because you have been diagnosed with prematureovarian insufficiency (POI).
Url
/Media/UHS-website-2019/Patientinformation/Womenshealth/Premature-ovarian-insufficiency-patient-information.pdf

BRC_Bridging Postdoc Fellowships-applicant guidelines_Round 1

Description
NIHR Southampton Biomedical Research Centre Postdoctoral Bridging Fellowships Applicant Guidelines Scheme Outline: The N
Url
/Media/Southampton-Clinical-Research/Downloads/BRC-Bridging-Postdoc-Fellowships-applicant-guidelines-Round-1.pdf

mini-RCHOP 21

Description
Chemotherapy Protocol LYMPHOMA CYCLOPHOSPHAMIDE-DOXORUBICIN-PREDNISOLONE-RITUXIMAB-VINCRISTINE (mini-RCHOP 21) Regimen   Lymphoma – mini-RCHOP (21)-Cyclophosphamide-Doxorubicin-PrednisoloneRituximab-Vincristine Indication
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/mini-RCHOP-21.pdf

InP-Bleomycin-Cisplatin-Etoposide (5 day BEP) Ver1.2

Description
Chemotherapy Protocol GERM CELL BLEOMYCIN-CISPLATIN-ETOPOSIDE (BEP 5 Day) In-Patient Regimen Regimen Germ Cell – InP-Bleomycin-Cisplatin-Etoposide (5
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Germcell/InP-Bleomycin-Cisplatin-Etoposide-5-day-BEP-Ver1.2.pdf

Bleomycin-Cisplatin-Etoposide (3 day BEP) Ver1.2

Description
Chemotherapy Protocol GERM CELL BLEOMYCIN-CISPLATIN-ETOPOSIDE (BEP 3 Day) Regimen Germ Cell – Bleomycin-Cisplatin-Etoposide (3 day BEP) Indication In
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Germcell/Bleomycin-Cisplatin-Etoposide-3-day-BEP-Ver1.2.pdf

Pembrolizumab_400mg (NSCLC)

Description
Chemotherapy Protocol LUNG CANCER Pembrolizumab (400mg) Regimen • Lung Cancer – Pembrolizumab (400mg) Indication The treatment of untreated PD-L1 positive metastatic non
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Pembrolizumab-400mg.pdf

Pembrolizumab 200mg (NSCLC)

Description
Regimen Chemotherapy Protocol LUNG CANCER Pembrolizumab (200mg) • Lung Cancer – Pembrolizumab (200mg) Indication The treatment of untreated PD-L1 positive metastatic non
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Pembrolizumab-200mg.pdf
461 to 470 of 985
Previous … 45 46 47 48 49 … Next